- January 15, 2016 | BY
A new global scourge, Obama’s moonshot at cancer and a proposal to use CRISPR in human embryo research.
- January 11, 2016 | BY
Recent FDA guidance on the development and validation of biomarkers was supposed to address questions about the accuracy and reliability of the data. Instead, it triggered debate
- January 8, 2016 | BY
The plight of the missing rodents, the future of optogenetics, the links between insomnia and dementia, and newcomers to the Periodic Table.
- January 7, 2016 | BY
An FDA panel steps in to resolve confusion over a standard screening tool for endotoxins. Stay tuned!
- January 4, 2016 | BY
With the growing number of citations and papers in the chemical literature, it’s not an understatement to say that the role of water molecules in drug design is a hot topic. Conceptually, it’s easy to see why.
- December 21, 2015 | BY
Rare CNS diseases are attracting more interest and research dollars in the pursuit of so-called niche-busters. CROs have a role to play.
- December 16, 2015 | BY
Animal research facilities are moving toward a sentinel-free system.
- December 14, 2015 | BY
What will be the fate of the Thorough QT Study in a post-CiPA world? Stay tuned as the field re-defines preclinical CVS risk assessment.
- December 11, 2015 | BY
Preventing GMO microbes from going rogue, a potential downside to optogenetics and a new farmaceutical. This week in Abstract Science.
- December 9, 2015 | BY
Diabetes and obesity is behind an alarming increase in non-alcoholic steatohepatitis (NASH). No approved therapies exist but there are glimmers of hope.